- alle zwei WochenErscheinungsrhythmus
- 1 h 08typische Länge
- vor 17 Std.letzte Folge
Folgenzu den neuesten
Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery
Tariq Kassum, CEO of Cambridge, Mass.-based Celsius Therapeutics, on using single cell technology for drug discovery.
Ep122: Aetna Wun Trombley on Extracellular Protein Degraders
Aetna Wun Trombley, CEO of Lycia Therapeutics, on extracellular protein degraders.
Ep121: Samantha Truex on Going Upstream Against Severe Asthma
Samantha Truex, CEO of Upstream Bio, on a new approach to treating severe asthma and other inflammatory diseases.
Ep120: Tim Lu on Gene Circuits for Cell Therapy
Tim Lu, CEO of Senti Biosciences, on developing gene circuits for cell therapy.
Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease
Jo Viney, CEO of Seismic Therapeutic, on discovering new treatments for autoimmune disease.
Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes
Ivan Liachko, CEO of Seattle-based Phase Genomics, on assembling accurate genomes and interactomes. He also discusses immigrating from Ukraine as a child, and what brought him and his family to the US.
Ep117: Dr. Sanduk Ruit on Restoring Eyesight in the Developing World
Dr. Sanduk Ruit of the Tilganga Institute in Kathmandu on restoring eyesight with affordable cataract surgery for the developing world.
Ep116: Ivana Magovcevic-Liebisch on Precision Neuroscience
Ivana Magovcevic-Liebisch, CEO of Vigil Neuroscience, on precision neuroscience drug development.
Ep115: Rahul Singhvi on Reimagining Biotech Manufacturing
Rahul Singhvi, CEO of Resilience, on rethinking the model for manufacturing of advanced biologics, gene and cell therapies.
Ep114: Chris Gibson on Industrializing Drug Discovery
Chris Gibson, co-founder and CEO of Recursion, on using new tools to industrialize drug discovery.
